Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K | 10-K/A |
| Revenues: |
| Colombia | | | | 4.1 |
| United States | | | | 59.6 |
| Total revenues | 592.2 | 488.1 | 278.5 | 63.7 |
| Revenue growth | 21.3% | 75.3% | 337.4% | |
| Cost of goods sold | 414.7 | 332.1 | 190.9 | 32.9 |
| Gross profit | 177.5 | 156.0 | 87.6 | 30.8 |
| Gross margin | 30.0% | 32.0% | 31.5% | 48.3% |
| Selling, general and administrative [+] | 288.0 | 246.0 | 219.0 | 52.0 |
| Sales and marketing | 220.5 | 190.5 | 56.5 | 28.3 |
| General and administrative | 67.6 | 55.5 | 162.4 | 23.6 |
| EBITDA [+] | -110.5 | -90.0 | -131.3 | -21.2 |
| EBITDA growth | 22.7% | -31.4% | 519.9% | |
| EBITDA margin | -18.7% | -18.4% | -47.2% | -33.3% |
| Depreciation | 2.7 | 1.2 | 0.5 | 0.1 |
| EBITA | -113.2 | -91.3 | -131.8 | -21.3 |
| EBITA margin | -19.1% | -18.7% | -47.3% | -33.4% |
| Amortization of intangibles | 11.6 | 3.0 | 1.6 | 1.0 |
| EBIT [+] | -124.8 | -94.3 | -133.4 | -22.3 |
| EBIT growth | 32.4% | -29.3% | 497.6% | |
| EBIT margin | -21.1% | -19.3% | -47.9% | -35.1% |
| Interest expense | 0.6 | 0.2 | 0.1 | 0.1 |
| Interest expense | 0.6 | 0.2 | 0.1 | 0.1 |
| Other income (expense), net [+] | | 28.1 | 4.8 | |
| Change in fair value of warrants | | 41.8 | 7.2 | |
| Pre-tax income | -125.4 | -66.4 | -128.7 | -22.5 |
| Income taxes | 9.0 | 4.7 | 2.9 | 0.0 |
| Tax rate | | | | 0.0% |
| Minority interest | -95.7 | -51.6 | -132.7 | |
| Net income | -38.6 | -19.5 | 1.1 | -22.5 |
| Net margin | -6.5% | -4.0% | 0.4% | -35.3% |
| |
| Basic EPS [+] | ($0.61) | ($0.35) | $0.02 | |
| Growth | 75.5% | -1496.4% | | |
| Diluted EPS [+] | ($0.61) | ($0.34) | $0.02 | |
| Growth | 79.2% | -1740.1% | | |
| |
| |
| Shares outstanding (basic) [+] | 63.5 | 56.3 | 43.6 | |
| Growth | 12.9% | 29.1% | | |
| Shares outstanding (diluted) [+] | 63.5 | 57.4 | 52.2 | |
| Growth | 10.6% | 9.9% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|